TORward AKTually useful mouse models

Nature Medicine

Volumn 10, Issue 6, 2004, Pages 579-580

  Mellinghoff, Ingo K ^a   Sawyers, Charles L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; IMATINIB; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE B; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER; CANCER CHEMOTHERAPY; CANCER MODEL; DRUG TARGETING; ENZYME ACTIVITY; ENZYME REGULATION; GENETIC ENGINEERING; MOUSE; NONHUMAN; PATIENT MONITORING; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, TRANSGENIC; NEOPLASMS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIROLIMUS;

ANIMALIA; MAMMALIA;

EID: 2942744435     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0604-579     Document Type: Short Survey

References (13)

1. Van Dyke, T. & Jacks, T. Cell 108, 135-144 (2002).
2. Majumder, P.K. et al. Nat. Med. 10, 594-601 (2004).
3. Neshat, M.S. et al. Proc. Natl. Acad. Sci. USA 98, 10314-10319 (2001).
4. Podsypanina, K. et al. Proc. Natl. Acad. Sci. USA 98, 10320-10325 (2001).
5. Aoki, M., Blazek, E. & Vogt, P.K. Proc. Natl. Acad. Sci. USA 98, 136-141 (2001).
6. Wendel, H.G. et al. Nature 428, 332-337 (2004).
7. Abraham, R.T. Curr. Top. Microbiol. Immunol. 279, 299-319 (2004).
8. Gorre, M.E. et al. Science 293, 876-880 (2001).
9. Dancey, J.E. & Freidlin, B. Lancet 362, 62-64 (2003).
10. Paez, J.G. et al. Science published online 29 April 2004 (doi: 10.1126/science. 1099314).
11. Lynch, T.J. et al. N. Engl. J. Med. (2004).
12. Manning, B.D. & Cantley, L.C. Trends Biochem. Sci. 28, 573-576 (2003).
13. Jaeschke, A., Dennis, P.B. & Thomas, G. Curr. Top. Microbiol. Immunol. 279, 283-298 (2004).